Registration - In-house Corporation

Baxter Corporation / Stephen Thompson, President & General Manager

Registration Information

In-house Corporation name: Baxter Corporation
Responsible Officer Name: Stephen Thompson, President & General Manager
Responsible Officer Change History
Initial registration start date: 2007-01-31
Registration status: Inactive
Registration Number: 930614-14650

Associated Communications

Total Number of Communication Reports: 17

Monthly communication reports in the last 6 months: 0

Version 22 of 22 (2020-06-05 to 2020-11-17)

Registration versions:

Version 22 of 22 (2020-06-05 to 2020-11-17)

Lobbying Information

Subject Matters

Aboriginal Affairs
Budget
Defence
Economic Development
Employment and Training
Environment
Government Procurement
Health
Industry
Internal Trade
International Relations
International Trade
Labour
Research and Development
Science and Technology
Taxation and Finance

Subject Matter Details

Legislative Proposal, Bill or Resolution

Federal Budget & Budget measures act with respect to health care funding and focus on science, technology & innovation
Regulatory Cooperation Council (RCC) work and focus on medical devices regulations

Policies or Program

Federal Innovation Panel (lead by Health Canada) - focused on medical technologies commercialization and adoption in Canada
Provide input into healthcare procurement guidelines that will foster innovative procurement models.
Science & Technology strategy with respect to the impact on commcercialization and/or procurement of medical technology in Canada

Policies or Program, Regulation

Comprehensive Economic and Trade Agreement (CETA), North American Free Trade Agreement (NAFTA) and Trans Pacific Partnership (TPP) trade discussions with a focus on medical devices regulations

Regulation

Provide input into information management and information technologies, including Digital Health and regulations related to patient data privacy.
Provide input on Health Canada’s "Action Plan on Medical Devices" and on Health Canada’s "Regulatory Review of Drugs and Devices" (R2D2).

Communication Techniques

Written communication
Oral communication
Grass-roots communication

Government Institutions

Canada Industrial Relations Board (CIRB)
Canadian Institutes of Health Research (CIHR)
Crown-Indigenous Relations and Northern Affairs Canada (CIRNAC)
Federal Economic Development Agency for Southern Ontario (FedDev)
Finance Canada (FIN)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Indigenous Services Canada (ISC)
Innovation, Science and Economic Development Canada (ISED)
NAFTA Secretariat
Office of the Procurement Ombudsman (OPO)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Public Health Agency of Canada (PHAC)
Public Safety Canada (PS)
Senate of Canada

In-house Corporation Details

Description of activities

Baxter Corporation (Canada) is the Canadian subsidiary of Baxter International, a global health care company. Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.

Responsible officer name and position during the period of this registration

Stephen Thompson, President & General Manager

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
7125 Mississauga Rd.
Mississauga, ON L5N 0C2
Canada

Telephone number: 905-369-6576

Parent Company Information

Baxter International
- One Baxter Parkway
  Deerfield, IL 60015-4625
  United States of America

Subsidiary Beneficiary Information

Baxter Corporation does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Emmanuel Lazaridis, Sr Manager, Market Access | No public offices held
James Teaff, Vice-President, Commercial | No public offices held
Stephen Thompson, President & General Manager | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

No lobbyists added

Baxter Corporation

The following names have been used on or after July 2, 2008

Name	From	To
Baxter Corporation	2010-03-09	2020-11-17

The following names have been used before July 2, 2008

Baxter Corporation

Baxter Corporation

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Stephen Thompson	2017-02-06	2020-11-17
Mike Oliver	2011-10-03	2015-11-02
Barbara Leavitt	2007-01-31	2011-10-03

Date Modified:: 2025-04-30

Search and menus

Language selection

Registration - In-house Corporation

Baxter Corporation / Stephen Thompson, President & General Manager

Registration Information

Associated Communications

Version 22 of 22 (2020-06-05 to 2020-11-17)

Version 22 of 22 (2020-06-05 to 2020-11-17)

Subject Matters

Subject Matter Details

Legislative Proposal, Bill or Resolution

Policies or Program

Policies or Program, Regulation

Regulation

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties